No photo of Lisa Ellen Flaum

View Scopus Profile

Lisa Ellen Flaum

  • 61 Citations
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My clinical practice involves the medical treatment of breast cancer in women and men with a particular interest in young women with breast cancer. My clinical research endeavors involve chemotherapy, endocrine therapy, and novel therapies for the treatment of breast cancer. I am interested in ways to optimize and individualize breast cancer treatment based on patient characteristics as well as tumor specific molecular profiles.

Certifications and Licenses

Medical Oncology
Hematology

Education/Academic qualification

MD, Georgetown University

… → 1998

Research interests

  • Breast Cancer
  • Cancer Genetics
  • Cancer Survivorship

Fingerprint Dive into the research topics where Lisa Ellen Flaum is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Prot# M02-446: A Phase II Study of ABT-751 in Subjects with Refractory Colorectal Carcinoma

Benson III, A. B., Flaum, L. E., Frankfurt, O. & Zakarija, A.

Abbott Laboratories

4/29/04 → 4/29/06

Project: Research project

Prot# MNTX 301: A Double-Blind Placebo Controlled Study of Methylnaltrexone (MNTX) for the Relief of Symptomatic Constipation Due to Chronic Opioid Therapy in Patients with Advanced Medical Illness

Flaum, L. E., Frankfurt, O. & Zakarija, A.

Progenics Pharmaceuticals, Inc.

4/7/04 → 4/5/07

Project: Research project

Prot# NCI R03L1: A Phase 2 Study of OSI 774 (IND# 63383) in Combination with Celecoxib (Celebrex, Pharmacia) as Second-Line Therapy in Advanced Non-Small Cell Lung Cancer (NCI prot# 5416) (Rush prot# Lung 2002-1)

Flaum, L. E., Frankfurt, O., Patel, J. D. & Zakarija, A.

Rush University Medical Center, Pfizer Inc.

3/22/04 → 1/1/08

Project: Research project

Prot# PSIND011: Mltctr Phz 1-2 Trial to Evaluate E&S of IDEC-Y2B8 (Zevalin) Radioimmunotherapy in Low-Grade, Follicular or Transformed B-Cell Non-Hodgkin's Lymphoma Patients Following Initial Response & Subsequent Relapse from Previous (NU Prot# UAB 0153)

Flaum, L. E., Frankfurt, O., Gordon, L. I. & Zakarija, A.

University of Alabama Medical School, Biogen Inc.

3/4/04 → 2/28/06

Project: Research project

Prot# 9238IL/0048: Rndmzd, Dbl-Bld, Mltctr Study to Compare Effic & Tolrblty of Fulvestrant (FASLODEX?) vs Exemestane (AROMASIN?) in Postmenopausal Women w/ Hormone Receptor Positive Advanced Breast Cancer w/ Disease Progression after Prior Non-Steroidal

Flaum, L. E., Frankfurt, O., Gradishar, W. J. & Zakarija, A.

AstraZeneca LP

2/18/04 → 11/21/11

Project: Research project

Research Output

  • 61 Citations
  • 6 Article
  • 3 Review article
  • 1 Chapter
  • 1 Comment/debate

Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)

Gerratana, L., Zhang, Q., Shah, A. N., Davis, A. A., Zhang, Y., Wehbe, F., Qiang, W., Flaum, L., Finkelman, B. S., Gradishar, W. J., Platanias, L. C., Behdad, A. & Cristofanilli, M., Jan 2020, In : Critical Reviews in Oncology/Hematology. 145, 102856.

Research output: Contribution to journal › Review article

Open Access

    • Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

    Davis, A. A., Zhang, Q., Gerratana, L., Shah, A. N., Zhan, Y., Qiang, W., Finkelman, B. S., Flaum, L., Behdad, A., Gradishar, W. J., Platanias, L. C. & Cristofanilli, M., Dec 4 2019, In : Breast Cancer Research. 21, 1, 137.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer

    Mutonga, M., Speedy, S., Rademaker, A., Liu, D., Uthe, R., Jain, S., Gradishar, W. J., Flaum, L. & Santa-Maria, C. A., Jul 15 2019, In : Breast Cancer Research and Treatment. 176, 1, p. 95-100 6 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Advances in endocrine therapy for postmenopausal metastatic breast cancer

    Flaum, L. E. & Gradishar, W. J., Jan 1 2018, Cancer Treatment and Research. Springer International Publishing, p. 141-154 14 p. (Cancer Treatment and Research; vol. 173).

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

    • 5 Scopus citations

    A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer

    Santa-Maria, C. A., Kato, T., Park, J. H., Kiyotani, K., Rademaker, A., Shah, A. N., Gross, L., Blanco, L. Z., Jain, S., Flaum, L., Tellez, C., Stein, R., Uthe, R., Gradishar, W. J., Cristofanilli, M., Nakamura, Y. & Giles, F. J., Apr 10 2018, In : Oncotarget. 9, 27, p. 18985-18996 12 p.

    Research output: Contribution to journal › Article

    • 16 Scopus citations